New patent for Alnylam Pharms drug ONPATTRO

   September 8, 2021    Comments Off on New patent for Alnylam Pharms drug ONPATTRO    Posted in: Patent Added

Annual Drug Patent Expirations for ONPATTRO Onpattro is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are twenty-one patents protecting this drug. Drug patent…

The post New patent for Alnylam Pharms drug ONPATTRO appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog